EU says U.S. pharma tariffs remain capped at 15% - reports
NeutralFinancial Markets
The European Union has confirmed that tariffs on U.S. pharmaceuticals will remain capped at 15%. This decision is significant as it helps maintain a stable trade relationship between the EU and the U.S., ensuring that consumers continue to have access to essential medications without facing steep price increases. It reflects ongoing negotiations and the importance of collaboration in the global pharmaceutical market.
— Curated by the World Pulse Now AI Editorial System